Ciprofloxacin inhibits proliferation and promotes generation of aneuploidy in Jurkat cells

• Autorzy: Koziel R. , Szczepanowska J. , Magalska A. , Piwocka K. , Duszynski J. , Zablocki K.
• Języki publikacji: EN

Abstrakty

EN

Ciprofloxacin is widely used in antimicrobial therapy. However it also inhibits mitochondrial topoisomerase II and therefore affects cellular energy metabolism. At a concentration exceeding 80 µg/ml ciprofloxacin induces apoptosis, while at 25 µg/ml it inhibits proliferation of Jurkat cells without any symptoms of cell death. The aim of this study was to explain the mechanisms of ciprofloxacin-evoked perturbations of the cell cycle. Human lymphoidal cells (Jurkat) were exposed to ciprofloxacin (25 µg/ml) for 4-11 days and effects of the drug on cell proliferation (light microscopy), cell cycle (flow cytometry), cell size and morphology (confocal microscopy) as well as number of chromosomes (chromosomal spread analysis) were investigated. Exposition of Jurkat cells to ciprofloxacin inhibited cell proliferation, increased proportion of cells in the G2/M-phase of the cell cycle, compromised formation of the mitotic spindle and induced aneuploidy. These observations indicate that ciprofloxacin applied at concentrations insufficient for induction of apoptosis may stop cell proliferation by inhibition of mitosis. Chromosomal instability of such cells may, at least potentially, increase a risk of cancer development.

Słowa kluczowe

EN

Jurkat cell; aneuploidy; antimicrobial therapy; apoptosis; cell cycle; cell death; cell proliferation; chromosome instability; ciprofloxacin; karyotype; mitochondrial topoisomerase; proliferation

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2010
• Tom: 61
• Numer: 2
• Opis fizyczny: p.233-239,fig.,ref.

Twórcy

autor

Koziel R.

• Nencki Institute of Experimental Biology, Warsaw, Poland

autor

Szczepanowska J.

autor

Magalska A.

autor

Piwocka K.

autor

Duszynski J.

autor

Zablocki K.

Bibliografia

• Castora FJ, Vissering FF, Simpson MV. The effects of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria. Biochim Biophys Acta 1983; 740: 417-427.
• Lawrence JW, Darkin-Rattray S, Xie F, Neims AH, Rowe TC. 4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells. J Cell Biochem 1993; 51: 165-174.
• Lawrence JW, Claire DC, Weissig V, Rowe TC. Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Mol Pharm 1996; 55: 178-188.
• Koziel R, Zablocki K, Duszynski J. Calcium signals are affected by ciprofloxacin as a consequence of reduction of mitochondrial DNA content in Jurkat cells. Antimicrob Agents Chemother 2006; 50: 1664-1671.
• Gerding DN, Hitt JA. Tissue penetration of the new quinolones in humans. Rev Infect Dis 1989; 11(Suppl 5): S1046-S1057.
• Smart DJ, Halicka HD, Traganos F, Darzynkiewicz Z, Williams GM. Ciprofloxacin-induced G2 arrest and apoptosis in TH6 lymphoblastoid cells is not dependent on DNA double-strand break formation. Cancer Biol Ther 2008; 7: 113-119.
• Aranha O, Grignon R, Fernandes N, McDonnel T, Wood DP Jr, Sarkar FH. Suppresion of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. Int J Oncol 2002; 22: 787-794.
• Aranha O, Zhu L, Alhasan S, Wood DP Jr, Kuo TH, Sarkar FH. Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells. J Urol 2002; 167: 1288-1294.
• Herold C, Ocker M, Ganslmayer M, Gerauer H, Hahn EG, Schuppan D. Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer 2002; 86: 443-448.
• Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE. Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro. J Orthop Res 1998; 16: 509-512.
• Somekh E, Douer D, Shaked N, Rubinstein E. in vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines. J Pharmacol Exp Ther 1989; 248: 415-418.
• Aranha O, Wood DP Jr, Sarkar FH. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res 2000; 6: 891-900.
• Makowska A, Zablocki K, Duszynski J. The role of mitochondria in the regulation of calcium influx into Jurkat cells. Eur J Biochem 2000; 267: 877-884.
• Pessina A, Bonomi A, Casati S, et al. Mitochondrial function, apoptosis and cell cycle delay in the WEHI-3B leukaemia cell line and its variant ciprofloxacin-resistant WEHI-3B/CPX. Cell Prolif 2007; 40: 568-579.
• Tsai W-C, Hsu C-C, Tang F-T, Wong AMK, Chen Y-C, Pang J-HS. Ciprofloxacin-mediated cell proliferation inhibition and G2/M cell cycle arrest in rat tendon cells. Arthritis Rheum 2008; 58: 1657-1663.
• Forsgren A, Bredberg A, Riesbeck K. Effects of ciprofloxacin on human lymphocytes – laboratory studies. Scand J Infect Dis 1989; Suppl 60: 39-45.
• Gollapudi SV, Prabhala RH, Thadepalli H. Effect of ciprofloxacin on mitogen-stimulated lymphocyte proliferation. Antimicrob Agent Chemother 1986; 29: 337-338.
• Jun Y-T, Kim H-J, Song M-J, et al. in vitro effects of ciprofloxacin and roxithromycin on apoptosis of Jurkat T lymphocytes. Animicrob Agent Chemother 2003; 47: 1161-1164.
• Forsgren A, Bergh A-K, Brandt M, Hansson G. Quinolones affect thymidine incorporation into the DNA of human lymphocytes. Antimicrob Agents Chemother 1986; 29: 506-508.
• Forsgren A, Bredberg A, Riesbeck K. New quinolones: in vitro effects as a potential source of clinical toxicity. Rev Infect Dis 1989; 11(Suppl 5): S1382-S1388.
• Riesbeck K, Forsgren A. Increased interleukin 2 transcription in murine lymphocytes by ciprofloxacin. Immunopharmacology 1994; 27: 155-164.
• Zehavi-Willner T, Shalit I. Enhancement of interleukin-2 production in human lymphocytes by two new quinolone derevatives. Lymphokine Res 1989; 8: 35-45.
• Riebeck K, Forsgren A, Henriksson A, Bredberg A. Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes. Antimicrob Agents Chemother 1998; 42: 1923-1930.
• Sliwinska MA, Mosieniak G, Wolanin K, et al. Induction of senescence with doxorubicin leeds to increased genomic instability of HCT116 cells. Mech Ageing Dev 2008; 130: 24-32.
• Kaszubowska L. Telomere shortening and ageing of the immune system. J Physiol Pharmacol 2008; 59(Suppl 9): 169-186.
• Riesbeck K, Andersson J, Gullberg M, Forsgren A. Fluorinated 4-quinolones induce hypeproduction of interleukin 2. Proc Natl Acad Sci USA 1989; 86: 2809-2813.
• Weaver BAA, Cleveland DW. Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res 2007; 67: 10103-10105.
• Kaczmarek M, Frydrychowicz M, Nowicka A, et al. Influence of pleural macrophages on proliferative activity and apoptosis regulating proteins of malignant cells. J Physiol Pharmacol 2008; 59(Suppl 6): 321-330.